Clinical Trials List
2025-06-30 - 2028-12-31
Phase I
Recruiting5
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- 沈士哲 Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- 周旭桓 Division of General Surgery
- Chun-Hsiu Liu Division of Ophthalmology
- 阮昱翔 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 魏慈慧 Division of General Surgery
- Zhu-Jun Loh Division of General Surgery
- Shang-Hung Chen Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- 黃怡菁 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Teng Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- 蘇孟夏 Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊明翰 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- MING-YANG WANG Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 李佳真 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 魏以宣 Division of Ophthalmology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
76 participants
